Immune therapy – where patients receive treatment that helps their immune system fight disease – is a growing area in fighting cancer. Now, a new study promises to make such treatments more effective – it has found a molecule called NF-kB that helps cancer cells evade the immune system.

Reporting in the journal Cell Reports, senior investigator Denis Guttridge, an assistant professor at Ohio State University Comprehensive Cancer Center, and colleagues suggest immune therapy for cancer might be more effective if combined with drugs that inhibit NF-kB.

READ FULL ARTICLE Curated publisher From Medical News Today